Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
592
datasets available to search
ShareScore release 0.9.0
Dataset results
592 results for “Cross-Sectional Studies”
Data from: Association between night-shift work, sleep quality, and health-related quality of life : a cross-sectional study among manufacturing workers in a middle-income setting
Open the record for dataset details and reuse information.
Data for: Evaluation of antibody kinetics and durability in health individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China
Open the record for dataset details and reuse information.
Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study
Open the record for dataset details and reuse information.
Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study
Open the record for dataset details and reuse information.
Data from: Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study
Open the record for dataset details and reuse information.
Awareness of fifth metatarsal stress fractures among soccer coaches in Japan: A cross-sectional study
Open the record for dataset details and reuse information.
Factors influencing the sustainability of homestead vegetable production intervention in Rufiji, Tanzania: A cross-sectional mixed methods study
Open the record for dataset details and reuse information.
Data from: Association of chronic obstructive pulmonary disease with risk of lung cancer in individuals aged 40 years and older: A cross-sectional study based on NHANES 2013-2018
Open the record for dataset details and reuse information.
Data from: Functional decline in facial expression generation in older women: a cross-sectional study using three-dimensional morphometry
Open the record for dataset details and reuse information.
Psychiatric manifestations and associated risk factors among hospitalized patients with COVID-19 in Edo State, Nigeria: A Cross-sectional Study
Open the record for dataset details and reuse information.
Public health emergency operations centres in Africa: A cross-sectional study assessing the implementation status of core components and areas for improvement, December 2021
Open the record for dataset details and reuse information.
Examining patterns in opioid prescribing for non-cancer-related pain in Wales: preliminary data from a retrospective cross-sectional study using large datasets
Open the record for dataset details and reuse information.
Cross-sectional and prospective data on Framingham risk score, allostatic load, and ankle brachial index among Puerto Rican adults from the Boston Puerto Rican Health Study
Open the record for dataset details and reuse information.
Evaluation of oxidative stress markers in Rwanda during the SARS-CoV-2 pandemic: a cross-sectional study
Open the record for dataset details and reuse information.
Stocks of paracetamol products stored in urban New Zealand households: A cross-sectional study
Open the record for dataset details and reuse information.
Raw data on Validation Study of the Revised Spirituality and Spiritual Care Rating Scale (SSCRS): A Cross-Sectional Survey in Poland
<p>Raw data on Validation Study of the Revised Spirituality and Spiritual Care Rating Scale (SSCRS): A Cross-Sectional Survey in Poland.</p>
Delays in emergency obstetrics referrals in Addis Ababa hospitals, Ethiopia: a facility-based, cross-sectional study
<p><b>Objectives: </b>To assess where the delays occur in the referral chain at most and maternal health outcomes based on the three delay model in Addis Ababa, Ethiopia.</p> <p><b>Design:</b> The study was a facility-based cross-sectional study</p> <p><b>Setting:</b> Two public and tertiary hospitals in Addis Ababa</p> <p><span class="fontstyle01"><span><b>Participants: </b></span></span><span class="fontstyle01"><span>All</span></span> pregnant women who were referred for only labor and delivery services after 28 weeks of gestation between December 2018 and February 2019 in Zewditu and Gandhi Memorial hospitals.</p> <p><b>Primary and secondary outcome measures</b>: The primary outcome was the type of delays from the three-delay model which met operationally defined time. Maternal health outcomes based on the three-delay model as a secondary outcome. </p> <p><b>Results: </b>A total of 403 pregnant women referred for delivery to the study hospitals were included in the study. Three-fourth (301, 74.7%) of referred pregnant women had the third delay (delayed receiving appropriate care); (211, 52.4%) had a first delay (delay in making a decision to seek care). Overall 366(90.8%) pregnant women had experienced at least one of the three delays and 71(17.6%) had all the three delays. Twenty-nine (7.2%) referred women had severe maternal outcomes (SMO). The most leading causes/diagnosis of SMO were blood transfusion 17 (58.6%) followed by postpartum hemorrhage 15 (52%) then eclampsia 9 (31%). In addition, women who experienced severe maternal outcomes were 2.9 times more likely to have at least one of the three delays.</p> <p><b>Conclusion & recommendation: </b>This study highlights the persistence of delays at all levels and especially delay three and its contribution to severe maternal outcomes. Strengthening health referral systems and addressing specific health system bottlenecks during labor and birth in order to ensure no mother will be endangered. We also recommend a qualitative method of study (focus group discussion and in-depth interview) and observing the tertiary hospitals set-up and readiness to manage obstetrics emergencies.</p>
Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada, and the United States with different regulatory controls: a cross-sectional study
<p><span><span><span><span><span><span><span><span><span><span><span><b>OBJECTIVE: </b>To assess if different forms of regulation lead to differences in the quality of journal advertisements.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>DESIGN: </b>Cross-sectional study.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>PARTICIPANTS: </b>Thirty advertisements from family practice journals published from 2013-2015 were extracted for three countries with distinct regulatory pharmaceutical promotion systems: Australia, Canada, and the United States (US). </span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>PRIMARY AND SECONDARY OUTCOME MEASURES: </b>Advertisements under each regulatory system were compared concerning three domains: information included in the advertisement, references to scientific evidence, and pictorial appeals and portrayals. An overall ranking for advertisement quality among countries was determined using the first two domains as the information assessed has been associated with more appropriate prescribing. </span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>RESULTS: </b>Advertisements varied significantly for number of claims with quantitative benefit (Australia: 0.0 (0.0-3.0); Canada: 0.0 (0.0-5.0); US: 1.0 (0.0-6.0); p=0.01); statistical method used in reporting benefit (RRR, ARR, and NNT) (Australia: 6.7%, n=2; Canada: 10.0%, n=3; US: 36.6%, n=11; p=0.02); mention of adverse effects, warnings, or contraindications (Australia: 13.3%, n=4; Canada: 23.3%, n=7; US: 53.3%, n=16; p=0.002); equal prominence between safety and benefit information (Australia: 25.0%, n=1; Canada: 28.6%, n=2; US: 75.0%, n=12; p=0.04); and methodologic quality of references score (Australia: 0.4150 (0.25-0.70); Canada: 0.25 (0.00-0.63); US: 0.25 (0.00-0.75); p<0.001). The US ranked first, Canada second, and Australia third for overall quality of journal advertisements. Significant differences for humor appeals (Australia: 3.3%, n=1; Canada: 13.3%, n=4; US: 26.7%, n=8; p=0.04), positive emotional appeals (Australia: 26.7%, n=8; Canada: 60.0%, n=18; US: 50.0%, n=15; p=0.03), social approval portrayals (Australia: 0.0%, n=0; Canada: 0.0%, n=0; US: 10.0%, n=3; p=0.04), and lifestyle or work portrayals (Australia: 43.3%, n=13; Canada: 50.0%, n=15; US: 76.7%, n=23; p=0.02) were found among countries.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>CONCLUSIONS:</b> <a name="_Hlk34742358">Different regulatory systems influence journal advertisement quality concerning all measured domains. </a>However, differences may also be attributed to other regulatory, legal, cultural, or health system factors unique to each country.</span></span></span></span></span></span></span></span></span></span></span></p>
Prevalence and correlates of overweight and obesity among adolescents in northeastern China: a cross-sectional study
<p>Abstract Objectives: To estimate the prevalence of overweight/obesity among adolescents and to evaluate the associated factors in this group in Changchun City, northeastern China.</p> <p>Methods: A cross-sectional study of 1955 adolescents aged 11–18 years was conducted in Changchun City, using stratified cluster sampling. Parents and caregivers of children completed the questionnaires as requested without objection; the questionnaire included demographic characteristics and anthropometric parameters. Univariate and multivariate logistic regression analyses were performed to analyze the relationship between overweight /obesity and related factors.</p> <p>Results: In total, the prevalence of overweight was 12.7% (male 17.4%; female 10.1%), and the prevalence of obesity was 4.9% (male 8.8%; female 3.1%) in Changchun, Jilin Province. The prevalence of overweight and obesity was higher in males than that in females (P <0.001). Multivariate logistic regression showed that overweight and obesity were significantly associated with male sex (OR=1.91, 95% CI: 1.48-2.47), eating fresh fruits more than two days per week (OR=1.41, 95% CI: 1.09-1.84), eating quickly (OR=1.37, 95% CI: 1.06-1.78). The students who were not picky (OR=0.69, 95% CI: 0.53-0.90) were less likely to be overweight. And adolescents whose father were overweight or obese (OR=0.67, 95% CI: 0.52-0.86) or mother were overweight or obese (OR=0.72, 95% CI: 0.52-0.99) were less likely to be overweight.</p> <p>Conclusion: The prevalence of overweight and obesity among adolescents in Changchun was high in recent years. The prevalence of overweight and obesity among males was higher than that among females. Sex, dietary habits (weekly frequency of fruit consumption, picky eating and slowness in eating) and parental weight were important factors for overweight and obesity in adolescents. Further research should be conducted on the health of adolescents in China and further intervention measures should be implemented to reduce the prevalence of overweight/obesity.</p>
Discordant Clostridioides difficile diagnostic assay and treatment practice: a cross-sectional study in a tertiary care hospital, Geneva, Switzerland
<p><b><span>Objectives:</span></b><span> </span><span><span>To determine the proportion of patients who received a treatment for </span><i><span>Clostridioides difficile</span></i><span> infection (CDI) among those presenting a discordant </span><i><span>Clostridioides difficile</span></i><span> diagnostic assay and to identify patient characteristics associated with the decision to treat CDI.</span></span></p> <p><b><span><span>Design: </span></span></b><span><span>Cross-sectional study.</span></span></p> <p><b><span><span>Setting: </span></span></b><span><span>Monocentric study in a tertiary care hospital, Geneva, Switzerland</span></span></p> <p><b><span>Participants: </span></b><span>Among 4562 adult patients tested for </span><i><span>C. difficile</span></i><span> between March 2017 and March 2019</span><span><span>, 208 patients with discordant tests' results</span></span><span> (positive nucleic acid amplification test [NAAT+]/negative enzyme immunoassay [EIA-]) were included.</span></p> <p><b><span>Main outcome measures:</span></b><span> </span><span><span>Treatment for CDI</span></span><span>.</span></p> <p><b><span>Results: </span></b><span><span>CDI treatment was administered in 147 (71%) cases</span></span><span>. In multivariate analysis, </span><span><span>an abdominal computed tomography scan</span></span><span> with signs of colitis (</span><span><span>OR 14.7; 95% CI 1.96-110.8) was the only factor associated with CDI treatment</span></span><span>.</span></p> <p><b><span>Conclusions:</span></b><span> The proportion of NAAT+/EIA- patients who received treatment questions the contribution of the EIA for the detection of toxin A/B after NAAT to limit </span><span><span>overtreatment</span></span><span>. Additional studies are needed to investigate if other factors are associated with the decision to treat.</span></p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.